An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 4 April 2013.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
Acceptance of the following patent applications has been opposed:
|2007343130||Methods of vaccine administration||Pfizer Products Inc.||Merial Limited|
Opposition to acceptance of the following applications have been withdrawn.
|2003246358||Catheter insertion device||B. Braun Melsungen AG||Terumo Corporation|
|2004293118||Neck brace||Xceed Holdings Close Corporation||Alpinestars SPA|
|2005201044||Method and medicament for inhibiting the expression of a defined gene||Alnylam Pharmaceuticals, Inc.||Sirna Therapeutics, Inc.|
|2011221358||Method For Producing A Synthetic Fibre For Use In An Artificial Grass Sports Field And Such A Synthetic Fibre||Ten Cate Thiolon B.V.||Tapex Pty Ltd|
Opposition proceedings of the following applications have been dismissed.
|2004230326||Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1H-imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives||Evultis||Merial Ltd|
No additional Applications for Opposition have been withdrawn:
Extensions of Term of Standard Patents
No application(s) for Extension of Term under Section 70 have been made.
No additional application(s) for Extension of Term have been accepted under Section 74.
No additional application(s) for Extension of Term have been refused.
The following application(s) for Extension of Term have been granted under Section 76:
|Patent No||Title||Applicant||Approval Date & Goods||Expiry Date|
|2007240156||Peptidomimetic protease inhibitors||Vertex Pharmaceuticals Incorporated||06 Mar 2012
For the goods INCIVO telaprevir
|31 Aug 2026|
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
No additional patents have been offered for surrender.
Revocation of Letters Patent
No additional patents have been wholly or partially revoked in accordance with Section 137 of the Patents Act.